Acquisition Of Zevacor Pharma Complete, Rebranding As SOFIE
28 September 2017
Sofie Biosciences, Inc., the molecular imaging company specializing in novel tools for PET imaging and radiosynthesis of PET compounds, has today announced the completion of the acquisition of Zeva